CN102176827B - 抗真菌制剂 - Google Patents

抗真菌制剂 Download PDF

Info

Publication number
CN102176827B
CN102176827B CN200980140485.1A CN200980140485A CN102176827B CN 102176827 B CN102176827 B CN 102176827B CN 200980140485 A CN200980140485 A CN 200980140485A CN 102176827 B CN102176827 B CN 102176827B
Authority
CN
China
Prior art keywords
mmol
compound
added
reaction
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200980140485.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN102176827A (zh
Inventor
M·L·格林李
R·威尔克宁
J·阿普加
D·斯珀尔贝克
K·J·维尔登格
孟东方
小D·L·帕克
G·J·珀考弗斯基
B·H·希斯利
A·玛麦
K·纳尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scynexis Inc
Original Assignee
Merck Sharp and Dohme Ltd
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102176827(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp and Dohme Ltd, Scynexis Inc filed Critical Merck Sharp and Dohme Ltd
Priority to CN201510182454.XA priority Critical patent/CN104877001B/zh
Publication of CN102176827A publication Critical patent/CN102176827A/zh
Application granted granted Critical
Publication of CN102176827B publication Critical patent/CN102176827B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN200980140485.1A 2008-08-12 2009-08-07 抗真菌制剂 Active CN102176827B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510182454.XA CN104877001B (zh) 2008-08-12 2009-08-07 抗真菌制剂

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13610108P 2008-08-12 2008-08-12
US61/136,101 2008-08-12
PCT/US2009/004560 WO2010019204A1 (en) 2008-08-12 2009-08-07 Antifungal agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510182454.XA Division CN104877001B (zh) 2008-08-12 2009-08-07 抗真菌制剂

Publications (2)

Publication Number Publication Date
CN102176827A CN102176827A (zh) 2011-09-07
CN102176827B true CN102176827B (zh) 2015-05-20

Family

ID=41669133

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200980140485.1A Active CN102176827B (zh) 2008-08-12 2009-08-07 抗真菌制剂
CN201510182454.XA Active CN104877001B (zh) 2008-08-12 2009-08-07 抗真菌制剂

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510182454.XA Active CN104877001B (zh) 2008-08-12 2009-08-07 抗真菌制剂

Country Status (7)

Country Link
US (1) US8188085B2 (cg-RX-API-DMAC7.html)
EP (1) EP2326181A4 (cg-RX-API-DMAC7.html)
JP (1) JP5548875B2 (cg-RX-API-DMAC7.html)
CN (2) CN102176827B (cg-RX-API-DMAC7.html)
AU (1) AU2009282474B2 (cg-RX-API-DMAC7.html)
CA (1) CA2731941C (cg-RX-API-DMAC7.html)
WO (1) WO2010019204A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103180301B (zh) 2010-08-26 2015-11-25 拜耳知识产权有限责任公司 5-碘代三唑衍生物
PT3247711T (pt) * 2015-01-19 2022-05-16 Scynexis Inc Novos sais e polimorfos de scy-078
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
PL3661503T3 (pl) 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph
JP7378401B2 (ja) * 2018-01-02 2023-11-13 サイネクシス,インコーポレーテッド リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
US12053486B2 (en) 2018-03-09 2024-08-06 Therazure LLC Compositions for the treatment of infections in feet
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques
AU2020228036B2 (en) 2019-02-27 2025-08-07 Scynexis, Inc. Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia
AU2020276595B2 (en) 2019-05-16 2025-12-04 Scynexis, Inc. Antifungal Agents for Candida Auris Decolonization
WO2021092349A1 (en) 2019-11-08 2021-05-14 Scynexis, Inc. Lipid-based formulations of scy-078 salts
WO2021097411A1 (en) * 2019-11-15 2021-05-20 The Research Foundation For The State University Of New York Anti-fungal compositions and methods for using same
CN118724779B (zh) * 2024-06-05 2025-09-23 浙江瑞博制药有限公司 一种醛基化合物的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960600B2 (en) * 2001-05-04 2005-11-01 Aventis Pharma S.A. Azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments
US7230023B2 (en) * 2001-02-22 2007-06-12 Sankyo Company, Limited Water-soluble triazole fungicide
US20080009504A1 (en) * 2006-04-03 2008-01-10 Balkovec James M Antifungal agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) * 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
DE69718141T2 (de) 1996-01-31 2003-08-21 Merck & Co., Inc. Fungizid
AU2002253456A1 (en) 2002-04-17 2003-10-27 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230023B2 (en) * 2001-02-22 2007-06-12 Sankyo Company, Limited Water-soluble triazole fungicide
US6960600B2 (en) * 2001-05-04 2005-11-01 Aventis Pharma S.A. Azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments
US20080009504A1 (en) * 2006-04-03 2008-01-10 Balkovec James M Antifungal agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
唑类抗真菌药物结构修饰的研发进展;王思袭等;《中国医药工业杂志》;20071231;第38卷(第1期) *

Also Published As

Publication number Publication date
AU2009282474A1 (en) 2010-02-18
US8188085B2 (en) 2012-05-29
EP2326181A4 (en) 2012-11-28
CN102176827A (zh) 2011-09-07
JP5548875B2 (ja) 2014-07-16
AU2009282474B2 (en) 2014-03-20
CN104877001A (zh) 2015-09-02
JP2011530593A (ja) 2011-12-22
CA2731941C (en) 2016-09-27
EP2326181A1 (en) 2011-06-01
HK1214271A1 (zh) 2016-07-22
WO2010019204A1 (en) 2010-02-18
CA2731941A1 (en) 2010-02-18
CN104877001B (zh) 2020-07-03
US20100113439A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
CN104877001B (zh) 抗真菌制剂
JP7240811B2 (ja) アムホテリシンbの誘導体
US20230016424A1 (en) Hybrid amide derivatives of amphotericin b
KR101686075B1 (ko) 항균제
CN102176828B (zh) 抗真菌制剂
HK1214271B (en) Antifungal agents
EP3917534B1 (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections
HK1158017B (en) Antifungal agents
HK40062374A (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections
HK40062374B (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Free format text: FORMER OWNER: SCYNEXIS INC.

Effective date: 20140911

Owner name: SCYNEXIS INC.

Free format text: FORMER OWNER: MERCK + CO. INC

Effective date: 20140911

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20140911

Address after: North Carolina

Applicant after: Scynexis Inc.

Address before: new jersey

Applicant before: Merck Sharp & Dohme

Applicant before: Scynexis Inc.

C14 Grant of patent or utility model
GR01 Patent grant